Statistics

Total Visits

Views
Sunitinib expanded-access trial in metastatic renal cell carcinoma (mRCC) - final results from Spain27

Select a period of time:

Number of views in the range

Views
Sunitinib expanded-access trial in metastatic renal cell carcinoma (mRCC) - final results from Spain18

Views

Views
October 20240
November 20241
December 20240
January 20250
February 20250
March 202516
April 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
Spain2
 

Top cities views

Views
Madrid1